|
|
||||||||
1 From the Departments of Ophthalmology and 3 Laboratory Medicine and Pathobiology, St. Michaels Hospital, University of Toronto, Ontario, Canada; 2 Health Sciences Research Center, St. Michaels Hospital, Toronto, Ontario, Canada; the 4 Glaucoma Center, University of California, San Diego; and the 5 Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison.
| Abstract |
|---|
|
|
|---|
METHODS. Seven cynomolgus monkeys with unilateral experimentally induced glaucoma and five control monkeys were studied. The left LGN neurons in magnocellular layer 1 and parvocellular layers 4 and 6, connected to the right glaucomatous eye were examined. Immunocytochemistry with antibody to parvalbumin was used to specifically label relay neurons connecting to the visual cortex. Neuronal cell body cross-sectional area was estimated using unbiased point-counting methodology. Experimental and control groups were compared using t-tests. Analysis of covariance (ANCOVA) tests were used to compare the percentage of decrease in mean neuronal area between layers 1, 4, and 6, as a function of percentage of optic nerve fiber loss or mean IOP. There was significant correlation between percentage of optic nerve fiber loss and mean IOP.
RESULTS. The mean cross-sectional area of relay neurons in magnocellular layer 1 and parvocellular layers 4 and 6 were significantly decreased in glaucoma compared with controls by 28%, 37%, and 45%, respectively. Neuronal area decreased in a linear fashion, with increasing optic nerve fiber loss or increasing mean IOP for layers 1, 4, and 6. The percentage of neuronal shrinkage in each of parvocellular layers 4 and 6, as a function of optic nerve fiber loss (P = 0.05; P = 0.001, respectively) or mean IOP (P = 0.046; P = 0.0008, respectively), was greater than that seen in magnocellular layer 1.
CONCLUSIONS. Relay neurons in the LGN, which project to the visual cortex, undergo significant shrinkage in glaucoma, and neurons in parvocellular layers undergo significantly more shrinkage than neurons in magnocellular layers.
| Introduction |
|---|
|
|
|---|
When disconnected from their major afferent pathways, neurons shrink and may subsequently die.6 Transneuronal degeneration is a well-known process in the extension of neurodegenerative diseases.8 9 In glaucoma, severe optic nerve fiber loss has been shown to be accompanied by loss of neurons in the lateral geniculate nucleus (LGN),10 in keeping with the concept of transneuronal degeneration. Studies of the optic nerve in glaucoma have shown evidence of preferential loss of larger fibers.11 12 13 In the central visual pathways, damage to both magnocellular and parvocellular pathways has been shown in the experimental monkey model of glaucoma10 14 15 16 17 18 ; however, it is controversial whether one of these pathways is preferentially affected. Whereas a recent study showed preferential loss of neurons in the LGN in magnocellular layers,17 another study described evidence of damage to both magno- and parvocellular LGN layers.18
Within the LGN, there are two types of neurons: inhibitory interneurons confined to the LGN and relay neurons that proceed to synapse in the visual cortex.19 20 Most of the degenerative and compensatory changes in the LGN occur in the relay neurons rather than interneurons after total deafferentation.21 22 We have previously shown loss of relay LGN neurons in both magno- and parvocellular layers in glaucoma.10 Using parvalbumin, a selective marker for relay neurons of the LGN,23 24 the purpose of this study was to determine whether there is atrophy of relay neurons in magnocellular and/or parvocellular LGN layers projecting to the visual cortex and to compare the degree of atrophy in magnocellular relay neurons with that in parvocellular relay neurons.
| Methods |
|---|
|
|
|---|
In experimental glaucoma and control monkeys, intraocular pressure (IOP) measurements were performed under light sedation with a pneumatonometer (Digilab, Norwell, MA) and an applanation tonometer (Goldmann; Haag-Streit, Koniz, Switzerland) respectively as previously described.10 In the ALT-treated right eyes, the interval between IOP measurements ranged from 5 to 39 days (mean, 26 days) over a 14-month period after laser trabeculoplasty. Table 1 summarizes the IOP values in the ALT-treated right eyes and in control monkeys. The mean IOP in the ALT-treated right eyes was significantly increased and ranged from 28.6 to 54.5 mm Hg. In all ALT-treated eyes, IOP measurements were above 21 mm Hg for at least 13 months. In control monkeys, mean IOP ranged from 14 to 21 mm Hg.
|
Tissue Processing
Under deep general anesthesia as previously
described,10
perfusion through the heart in experimental
and control animals was performed with 4% paraformaldehyde, 0.1%
glutaraldehyde, and 4% paraformaldehyde, respectively, in 0.1 M
phosphate buffer (pH 7.4). For tissue processing and serial coronal
50-µm sectioning of the LGN, care was taken to ensure the same
procedures for all monkey brains.10
Immunocytochemistry
The primary antibody was a monoclonal antibody against
parvalbumin (clones PA-235; Sigma, St. Louis, MO). Parvalbumin, a
calcium-binding protein, labels relay neurons in the LGN layers that
project axons to the visual cortex.23
24
Tissue sections
were immunostained, according to a previously described
protocol.10
Morphometry
The tissue was viewed using a bright-field microscope (Reichert
Jung, Vienna, Austria) with a color video camera (JVC, Yokohama,
Japan), video, and computer monitors. The six layers of the LGN were
easily identified on stained sections. The ventral layers 1 and 2 are
magnocellular layers, whereas the remaining dorsal layers three to six
are parvocellular layers. Layers 1, 4, and 6 of the left LGN are
connected to the right eye (glaucomatous, in this study), whereas
layers 2, 3, and 5 are connected to the left eye (nonglaucomatous). To
determine whether neurons in magnocellular and/or parvocellular LGN
layers connected to a glaucomatous eye are shrunken, the
cross-sectional area of neurons in the left LGN layers 1, 4, and 6 were
measured, and the measurements were compared with those from the left
LGN layers 1, 4, and 6 in control monkeys. Retinal ganglion cells
(RGCs) of the right nasal hemiretina and fovea project to the left LGN
layers 1, 4, and 6 and compose approximately 50% of the right eye
RGCs.27
The difference in number of surviving nerve fibers
between the nasal and temporal quadrants of the right optic nerves was
not statistically significant in experimental glaucoma
(P > 0.05) in the monkeys examined in this study;
therefore, changes observed in the left LGN layers 1, 4, and 6 are
representative of changes observed in target LGN neurons. Left LGN
layers 1, 4, and 6 of monkeys with a normal visual system were used as
controls rather than the left LGN layers adjacent to examined layers 2,
3, and 5 or the right LGN layers 1, 4, and 6 of the laser-treated
monkeys, because a significant decrease in cell size has been observed
in undeprived layers under monocular experimental
conditions.28
Measurements were performed on three sections representative of the
anterior, middle, and posterior parts of each LGN. Cross-sectional area
measurements were made on parvalbumin-immunostained sections at high
power using an oil immersion objective (x100, numeric aperture, 1.32),
bright-field microscope, and color video camera. Immunostained neurons
were visualized on the computer and video monitors. Cell body
cross-sectional area measurements were made at locations determined by
a random and systematic sampling procedure using a superimposed grid
method.29
Computer software (Neurozoom; Human Brain
Project, La Jolla, CA) enabled digital superposition of the sampling
grids on the tissue. Only sample locations within the LGN layers were
used for cross-sectional area measurements. The size of the sampling
grid was adjusted for each layer so that there were at least 65 samples
for that layer through the nucleus. To measure cross-sectional areas in
an unbiased fashion, optical dissector methodology was used to assess
the maximum cross-sectional area. A three-dimensional optical box was
composed of x, y, and z axes of
50 x 50 x 10 µm, respectively. A 50 x 50-µm
counting frame was projected onto the video monitor. By measuring only
neurons completely within the frame and intersecting the upper or
righthand borders, sampling bias was minimized.30
The
cross-sectional area of new neurons that came into focus as the
operator focused through the optical box was measured. The excursion
along the focusing axis (10 µm) and the thickness of the section were
measured with a microcator (MT12; Heidenhain, Traunreut, Germany)
mounted on the microscope stage. A point-counting grid generated by the
software was visualized on the computer monitor. Using the mouse, the
operator marked the points located on a cell body. Each point
corresponded to an area of 4 µm2 for the grid
used for all layers. The cross-sectional area of the cell body was
calculated by multiplying the number of points on the cell body with
the area corresponding to a grid point by the software. Neuronal cell
body cross-sectional area per layer was estimated by calculating the
average cross-sectional area for at least 67 neurons. Neuronal radius
was calculated as the square root of the cross-sectional area divided
by
.
Statistical Analysis
Students t-test was used to compare the mean
cross-sectional area means of neurons in the LGN of glaucomatous versus
control monkeys. To assess atrophic changes, neuronal area percentage
decrease (percentage of neuronal shrinkage) was used as the dependent
variable. Neuronal area percentage decrease for each layer of each
animal subject was calculated as the mean of neuronal area means in a
given layer of the control group minus the mean neuronal area divided
by the mean of neuronal area means for the control group. The
relationships between percentage of neuronal shrinkage and percentage
of optic nerve fiber loss and between percentage of neuronal shrinkage
and mean IOP were assessed separately, using linear regression models.
To compare percentage of neuronal shrinkage among magnocellular layer 1 and parvocellular layers 4 and 6, two analyses of covariance (ANCOVA) were performed (GLM procedure of Statistical Analysis Software; SAS, Cary, NC) one for percentage of optic nerve fiber loss and one for mean IOP. The dependent variable was always percentage of neuronal shrinkage, and the layer was the grouping factor. Using the interaction term between percentage of neuronal shrinkage and layer, we determined whether the slopes were significantly different. The model, without the interaction term enabled assessment of whether the means differed among the three layers, and of which combinations of means, if any, were significantly different.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
According to our results, relay neurons in magno- and parvocellular layers undergo atrophy in experimental glaucoma. The mean neuronal shrinkage observed in the two glaucomatous animals with complete optic nerve fiber loss in this study was similar to that observed by Matthews6 12 months after ocular enucleation: 43% vs. 54% in magnocellular layer 1, 49% vs. 66% in parvocellular layer 4, and 62% vs. 66% in parvocellular layer 6.
The present study demonstrates for the first time in the central nervous system that cell size decrease relates to the degree of deafferentation, previously suggested by findings in studies of the olfactory system33 and somatosensory sytem.34 The linear relationship between the degree of optic nerve damage and degree of atrophy in relay LGN neurons suggests a link between loss of retinal ganglion cells and shrinkage of their target neurons. Although significant input to the LGN from the cortex and several subcortical structures has been described,35 36 atrophic changes observed in target relay neurons appears to be directly related to the loss of connections with RGCs, the major afferent input to the LGN. In addition, the linear relationship found in this study between shrinkage of relay neurons and mean IOP is in keeping with the correlation previously noted between atrophy of Nissl-stained neurons and mean IOP.17 We also observed significant neuronal shrinkage in monkeys with ocular hypertension and no optic nerve fiber loss, suggesting that neuronal atrophy in the LGN may be an early event, at least partially related to elevated IOP. Statistical determination of which of these parameters (i.e., optic nerve fiber loss or IOP) is more important in atrophy was not possible in this study, because of the large sample size needed for this type of analysis.
Our results also suggest that atrophy of relay neurons in parvocellular layers is greater than that observed in magnocellular layers in glaucoma. In two monkeys with complete optic nerve fiber loss, neuronal atrophy was noted in both magno- and parvocellular layers, as may be expected. In addition, neuronal atrophy appeared to be more severe in parvocellular layers than in magnocellular layers, in keeping with previous studies showing that neuronal atrophy is more severe in parvo- than in magnocellular layers after enucleation1 6 and similar to observations in human LGN after enucleation.37 Investigators in a recent study were unable to detect a differential cell size effect between magno- and parvocellular neurons in experimental glaucoma.17 In addition to overall shorter survival times compared with that of the present study, the difference may be due to the criterion used to identify neuronsnamely, the presence of a distinct nucleolus.17 Because this organelle is known to shrink during transneuronal degeneration, this criterion may have introduced a bias in the selection of neurons that show less atrophy for area measurement.38 Finally, Nissl stain labels relay neurons in addition to interneurons. The interneurons, confined to the LGN, are relatively resistant to transneuronal degeneration, and interneurons demonstrate less atrophic change compared with relay neurons after enucleation.21 22 This, combined with the fact that magnocellular layers are known to have a greater percentage of interneurons than parvocellular layers,19 may also explain why no relative difference in atrophy between magnocellular and parvocellular layers was detected in the previous study.17 In addition, the seven monkeys in our study each had a longer survival time of 14 months compared with survival times ranging from 0.5 to 6 months with similar mean IOP.17
Neuronal atrophy is believed to precede neuronal loss. Mathews et al.4 6 showed that whereas neuronal atrophy occurred within 6 months after ocular enucleation, loss of neurons was not seen until 12 months after ocular enucleation. In the present study, the shrinkage of LGN neurons in experimental glaucoma was found at both early and advanced stages of glaucomatous damage, and increased in a linear fashion with optic nerve fiber loss. However, significant loss of LGN magnocellular neurons (68% and 61%) and parvocellular neurons (60% and 68%) was restricted to monkeys with optic nerve fiber loss of 61% and 100%, respectively.10 That neuronal atrophy precedes neuronal loss is not supported by the results of a recent study in which significant neuronal loss in the magnocellular layer was reported as early as 2.5 weeks after IOP elevation and before the detection of significant atrophy.17 This discrepancy is probably explained by the difficulty in detecting the nucleolus (the criterion used by the investigators to identify neurons), particularly in atrophic neurons with shrunken nucleolus.38
In this study, optic nerve fiber loss ranged from 0% to 100% and mean optic nerve fiber loss was 45%. Although this range of optic nerve fiber loss may reflect the full spectrum of glaucomatous optic nerve damage in humans, further studies are needed to assess the degree of neuronal atrophy in LGN and its relationship to the degree of optic nerve fiber loss in human glaucoma.
The presence of degeneration in LGN neurons has several implications regarding progressive glaucomatous damage. The target neurons may provide trophic support for RGCs and in fact, damage to LGN neurons has been shown to cause RGC atrophy and degeneration.39 The degeneration of LGN neurons in experimental glaucoma may increase the susceptibility of surviving RGCs to ongoing damage. Additionally, the changes in relay LGN neurons that project to visual cortex, may explain in part the metabolic and neurochemical changes seen in the primary visual cortex in glaucoma.15 18 40 41 We propose that in addition to therapies to rescue RGCs directly, neuroprotective strategies to rescue LGN neurons in glaucoma may further enhance RGC survival. Indeed, a neurotrophic factor has been shown to prevent the atrophy in LGN neurons induced by monocular visual deprivation.42 Although the mechanisms underlying neuronal atrophy are not yet known, understanding the atrophic process in glaucoma may provide insights into glaucomatous progression and its prevention.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication April 19, 2001; revised July 30, 2001; accepted August 10, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: Yeni H. Yücel, Ophthalmic Pathology Laboratory, Department of Ophthalmology, University of Toronto, 1 Spadina Crescent, Suite 125, Toronto, Ontario, Canada M5S 2J5. yeni.yucel{at}utoronto.ca
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. J. Weber, C. D. Harman, and S. Viswanathan Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina J. Physiol., September 15, 2008; 586(18): 4393 - 4400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. O. Duncan, P. A. Sample, R. N. Weinreb, C. Bowd, and L. M. Zangwill Retinotopic Organization of Primary Visual Cortex in Glaucoma: A Method for Comparing Cortical Function with Damage to the Optic Disk Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 733 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Castelo-Branco, M. F. Silva, C. Januario, and A. Freire Reply to "Letter to the Editor: Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease (Silva MF et al. Brain 2005; 128: 2260-2271)." Concomitant impairment of multiple visual pathways in Parkinson's disease Brain, December 1, 2006; 129(12): e62 - e62. [Full Text] [PDF] |
||||
![]() |
N Gupta, N Krishnadev, S J Hamstra, and Y H Yucel Depth perception deficits in glaucoma suspects Br. J. Ophthalmol., August 1, 2006; 90(8): 979 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Alm How much is the brain involved in glaucoma? Br. J. Ophthalmol., June 1, 2006; 90(6): 663 - 664. [Full Text] [PDF] |
||||
![]() |
N Gupta, L-C Ang, L N. de Tilly, L Bidaisee, and Y H Yucel Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex Br. J. Ophthalmol., June 1, 2006; 90(6): 674 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Yucel, N. Gupta, Q. Zhang, A. P. Mizisin, M. W. Kalichman, and R. N. Weinreb Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol, February 1, 2006; 124(2): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Brooks, M. E. Kallberg, R. L. Cannon, A. M. Komaromy, F. J. Ollivier, O. E. Malakhova, W. W. Dawson, M. B. Sherwood, E. E. Kuekuerichkina, and G. N. Lambrou Functional and Structural Analysis of the Visual System in the Rhesus Monkey Model of Optic Nerve Head Ischemia Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1830 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amin, N. H. V. Chong, T. A. Bailey, J. Zhang, C. Knupp, M. E. Cheetham, J. Greenwood, and P. J. Luthert Modulation of Sub-RPE Deposits In Vitro: A Potential Model for Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1281 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. G. Martin, H. A. Quigley, D. J. Zack, H. Levkovitch-Verbin, J. Kielczewski, D. Valenta, L. Baumrind, M. E. Pease, R. L. Klein, and W. W. Hauswirth Gene Therapy with Brain-Derived Neurotrophic Factor As a Protection: Retinal Ganglion Cells in a Rat Glaucoma Model Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4357 - 4365. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kashiwagi, B. Ou, S. Nakamura, Y. Tanaka, M. Suzuki, and S. Tsukahara Increase in Dephosphorylation of the Heavy Neurofilament Subunit in the Monkey Chronic Glaucoma Model Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 154 - 159. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |